- Ebstein's anomaly
Infobox_Disease
Name = PAGENAME
Caption =
DiseasesDB = 4039
ICD10 = ICD10|Q|22|5|q|20
ICD9 = ICD9|746.2
ICDO =
OMIM = 224700
MedlinePlus =
eMedicineSubj = med
eMedicineTopic = 627
MeshID = D004437Ebstein's anomaly is a
congenital heart defect in which the opening of thetricuspid valve is displaced towards the apex of theright ventricle of theheart .Presentation
The annulus of the valve is still in the normal position. The valve leaflets, however, are to a varying degree, attached to the walls and septum of the right ventricle. There is subsequent atrialization of a portion of the morphologic right ventricle (which is then contiguous with the right atrium). This causes the right atrium to be large and the anatomic right ventricle to be small in size.
Risk factors
There may be an increased risk of this abnormality in infants of women taking lithium during the first trimester of pregnancy, and in those with
Wolff-Parkinson-White syndrome .History
Ebstein's anomaly was named after
Wilhelm Ebstein . [WhoNamedIt|synd|435] [W. Ebstein. Über einen sehr seltenen Fall von Insufficienz der Valvula tricuspidalis, bedingt durch eine angeborene hochgradige Missbildung derselben. Archiv für Anatomie, Physiologie und wissenschaftliche Medicin, Leipzig, 1866, 238-254.]Related abnormalities
While Ebstein's anomaly is defined as the congenital displacement of the tricuspid valve towards the apex of the right ventricle, it is often associated with other abnormalities.
Anatomic abnormalities
Typically, there are anatomic abnormalities of the tricuspid valve, with enlargement of the anterior leaflet of the valve.
About 50% of individuals with Ebstein's anomaly have an associated shunt between the right and left atria, either an
atrial septal defect or apatent foramen ovale .Electrophysiologic abnormalities
About 50% of individuals with Ebstein's anomaly have evidence of
Wolff-Parkinson-White syndrome , secondary to the atrialized right ventricular tissue.Management
Pharmacological
Ebstein's cardiophysiology typically presents as an atrioventricular reentrant tachycardia with associated preexcitation. In the acute setting with EKG evidence of preexcitation, the preferred pharmacological treatment agents include
procainamide oributilide since these medications slow conduction in the accessory pathway causing the tachycardia and should be administered before considering electricalcardioversion .References
External links
* [http://heartcenter.seattlechildrens.org/conditions_treated/ebsteins_malformation.asp Ebstein's Malformation information] from Seattle Children's Hospital Heart Center
* [http://www.kumc.edu/instruction/medicine/pedcard/cardiology/pedcardio/ebsteinsdiagram.gifDiagram at kumc.edu]
* [http://www.mayoclinic.org/ebsteins-anomaly/abnormalities.html Overview and diagram] atMayo Clinic
* [http://www.emedicine.com/med/topic627.htm Ebstein Anomaly article from eMedicine]
Wikimedia Foundation. 2010.